# FDA 483 - My CHS Rx, Inc. - June 05, 2026

Source: https://www.keypedia.com/records/483/my-chs-rx-inc/3be408a8-8e45-428f-80c6-e8f203640ba8

> FDA 483 for My CHS Rx, Inc. on June 05, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: My CHS Rx, Inc.
- Inspection Date: 2026-06-05
- Product Type: drugs
- Office Name: New York District Office
- Summary: My CRS Rx, Inc., a drug repackager and relabeler in Hauppauge, NY, was cited for significant deficiencies in its quality system during an FDA inspection. The firm lacked a functional quality control unit, failed to implement a CGMP training program for employees, and did not properly qualify equipment or validate packaging and labeling processes. These issues indicate a broad failure to adhere to current good manufacturing practices.

## Related Officers

- [Luxuly Abraham](https://www.keypedia.com/people/luxuly-abraham/d33e3164-ec89-488b-bab9-a9ec30544970)

Company: https://www.keypedia.com/companies/my-chs-rx-inc/e02939d1-a13d-4e39-8736-13c6def752b7

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d